The guide highlights the essential shift in pharmaceutical quality management from document-centric to data-centric approaches, driven by the need to overcome unstructured data and siloed processes in a complex regulatory environment.
It advocates adopting connected quality platforms, like MasterControl, that integrate with enterprise systems to enable quality across the supply chain. Leveraging advanced technologies such as analytics and AI provides predictive insights, helping pharma companies accelerate time-to-market, improve compliance, and boost efficiency through smarter data use.
The source highlights the importance of adopting a modern Manufacturing Execution System (MES) in the pharmaceutical industry. In a complex, highly regulated environment, traditional paper-based or legacy systems cause inefficiencies and errors. A cloud-based MES like MasterControl Manufacturing Excellence bridges the gap between ERP and process control systems, offering real-time data visibility and control.
Key benefits include reduced production errors, paperless efficiency, faster batch reviews, and automation of critical tasks such as equipment calibration and review by exception. Implementing a modern MES is crucial to achieving Pharma 4.0 goals and staying competitive in an era of personalized medicine and smaller batch production.
MasterControl’s research on digital maturity in pharmaceutical and medtech manufacturing reveals many companies still rely on manual, paper-based, and siloed systems despite innovations. Surveying 152 life sciences professionals, the study identifies four maturity levels—Manual, Digital, Connected, and Intelligent—and finds MES often only partially implemented.
Key digitization drivers are competitive advantage and improved connectivity, while cost and implementation time remain barriers. The report urges broader adoption of modern, integrated MES to reduce inefficiencies, data issues, and human errors, helping companies achieve higher operational intelligence and optimization.